Larissa Costa de Almeida

Larissa Costa de Almeida

Auto-generated profile, based on publicly available information

Larissa Costa de Almeida

Institute of Biomedical Sciences, University of São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2018 in Natural Product Research
Verified
Journal Article
Closed access
ABAnelize Bauermeister
Anelize Bauermeister
FCFelipe A. Calil
Felipe A. Calil
FPFrancisco das C. L. Pinto
Francisco das C. L. Pinto
TMTalita C. T. Medeiros
Talita C. T. Medeiros
LALarissa C. Almeida
Larissa C. Almeida
LMLuiz Alberto Beraldo Moraes
Luiz Alberto Beraldo Moraes
A new polycyclic antibiotic, pradimicin-IRD, was isolated from actinobacteria Amycolatopsis sp. IRD-009 recovered from soil of Brazilian rainforest undergoing restoration area. This molecule is the major compound produced in solid culture media. The new compound was detected by a focused method of precursor ion (high-performance liquid chromatography coupled to tandem mass spectrometer) developed previously to identify unusual aminoglycosyl sugar moieties. The compound was isolated and its structure was, therefore, elucidated by high-resolution mass spectrometry, and 1D and 2D nuclear magnetic resonance experiments. Pradimicin-IRD displayed potential antimicrobial activity against Streptococcus agalactiae (MIC 3.1 μg/mL), Pseudomonas aeruginosa (MIC 3.1 μg/mL) and Staphylococcus aureus (MIC 3.1 μg/mL), and also cytotoxicity against tumour and non-tumour cell lines with IC50 values ranging from 0.8 μM in HCT-116 colon carcinoma cells to 2.7 μM in MM 200 melanoma cells. Particularly, these biological properties are described for the first time for this chemical class.

10 November 2023 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KWKaroline Barros Waitman
Karoline Barros Waitman
LALarissa C. de Almeida
Larissa C. de Almeida
MPMarina C. Primi
Marina C. Primi
JCJorge A.E.G. Carlos
Jorge A.E.G. Carlos
CRClaudia Ruiz
Claudia Ruiz
Roberto Parise-FilhoRoberto Parise-Filho
Roberto Parise-Filho

19 March 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
HHHaifa Hassanie
Haifa Hassanie
APAndré Berndt Penteado
André Berndt Penteado
LALarissa Costa de Almeida
Larissa Costa de Almeida
RCRaisa Ludmila Calil
Raisa Ludmila Calil
FEFlavio Emery
Flavio Emery
GTGustavo Trossini
Gustavo Trossini
The SETDB1 protein's structure and primary function are succinctly described in this review article. It also gives light on potential inhibitory mechanisms that, in the future, can be employed as a cancer target.